ORGANIC
LETTERS
2011
Vol. 13, No. 8
2086–2089
Regiocontrolled Rearrangement of
Isobenzofurans
Ben A. Egan,† Michael Paradowski,‡ Lynne H. Thomas,§ and Rodolfo Marquez*,†,
WestCHEM, University of Glasgow, Joseph Black Building, University Avenue,
Glasgow G12 8QQ, United Kingdom, Pfizer Global R&D, Sandwich, Kent CT13 9NJ,
United Kingdom, and Department of Chemistry, University of Bath, Bath BA2 7AY,
United Kingdom
Received February 23, 2011
ABSTRACT
The regioselective alkylation and oxidative rearrangement of isobenzofurans has been achieved to generate substituted 4,8-
dihydroxyisochromanones in good yields and with complete regiocontrol.
Isochroman-1-ones are pharmacophores present in a
number of natural products with therapeutic potential.1
The 4,8-dihydroxyisochroman-1-one motif is particularly
significant, as it is a key structural component in a number
of biologically active metabolites such as the ajudazols 1,2
acetoxygeranyloxymellein 2,3 thailandolide 3,4 the Hel-
minthosporium monoceras antifungal metabolite 4,5 and
(4R)-hydroxyochratoxin 5 (Figure 1).6
However, despite their potential as therapeutic leads, the
approaches currently available for the syntheses of sub-
stituted 4,8-dihydroxyisochroman-1-ones tend to be either
low yielding or not flexible enough for the efficient gen-
eration of analogues.
Figure 1. 4,8-Dihydroxyisochroman-1-one containing natural
products.
† University of Glasgow.
‡ Pfizer Global R&D.
§ University of Bath.
Ian Sword Reader of Organic Chemistry and EPSRC Leadership Fellow.
(1) Wittig, G.; Pohmer, L. Chem. Ber. 1956, 89, 1334.
(2) (a) Jansen, R.; Kunze, B.; Reichenbach, H.; Hofle, G. Eur. J. Org.
Chem. 2002, 917. (b) Kunze, B.; Jansen, R.; Hofle, G.; Reichenbach, H.
J. Antibiot. 2004, 57, 151.
(3) Appendino, G.; Ozen, H. C.; Jakupovic, J. Phytochemistry 1994,
36, 531.
(4) Dethoup, T.; Manoch, L.; Kijjoa, A.; Pinto, M.; Gales, L.;
Damas, A. M.; Silva, A. M. S.; Eaton, G.; Herz, W. J. Nat. Prod.
2007, 70, 1200.
Recently, we reported the fast and efficient synthesis of
simple 4-hydroxyisochroman-1-one units 7 through a
high-yielding four-step sequence starting from phthalan
6. The entire process requires minimal purification and
does not require the isolation of any of the intermediate
species (Scheme 1).7
Mechanistically, we believe that the phthalan unit 6 is
deprotonated with LDA to generate the unstable
(5) Arai, K.; Ooka, M.; Koizumi, F.; Koda, S.; Iwasaki, Y.;
Kanemoto, Y. U.S. Patent Int. 5,530,146, 1996.
(6) Zepnik, H.; Pahler, A.; Schauer, U.; Dekant, W. Toxicol. Sci.
2001, 59, 59.
(7) Hobson, S. J.; Parkin, A.; Marquez, R. Org. Lett. 2008, 10, 2813.
r
10.1021/ol200498k
Published on Web 03/23/2011
2011 American Chemical Society